Press Release: Corvidia : Corvidia Therapeutics to Participate in 2019 Jefferies Global Healthcare Conference
WALTHAM, Mass., June 4, 2019 /PRNewswire/ -- Corvidia Therapeutics Inc., a clinical stage biotechnology company, today announced Marc de Garidel, chief executive officer will present in the Jefferies 2019 Global Healthcare Conference in New York City on Friday, June 7 at 9:30 am....
Read full article »
Corvidia is a pharmaceutical firm that develops and commercializes novel therapeutics for the treatment of cardiorenal and chronic kidney disorders.
Read more